Low-dose temozolomide selectively increases glioblastoma's vascular permeability, tumor microenvironment penetration and the killing potential of systemic actinium-225 α-particle dendrimer-radioconjugates improving treatment efficacy. - Nair, Rajiv Ranjit; Sarkar, Aira; Hariharan, Pooja; Gabrielson, Kathleen L.; Wu, Tony; Liu, Chang; Sharma, Anjali; Liyanage, Wathsala; Bhujwalla, Zaver M.; Vidaver, Marie-France Penet; Kannan, Rangaramanujam M.; Sofou, Stavroula (European Journal of Nuclear Medicine & Molecular Imaging, 2025)